IMAX is not a strong buy at the moment for a beginner investor with a long-term focus. While the company shows positive growth trends in revenue and gross margin, the significant drop in net income and EPS, combined with insider selling and neutral hedge fund sentiment, suggests caution. Additionally, technical indicators do not signal a strong entry point, and no proprietary trading signals are present to support immediate action. The stock may be worth monitoring for future opportunities, but it does not currently align with the user's investment strategy.
The MACD is below 0 and negatively contracting, RSI is neutral at 42.985, and moving averages are converging. The stock is trading near its pivot point of 37.727, with resistance levels at 39.098 and 39.945, and support levels at 36.355 and 35.508. No strong trend or breakout signal is evident.

IMAX reported a 35.11% YoY increase in revenue for Q4 2025, driven by strong box office performance and system installs. The company is benefiting from a resurgence in theater audiences and has a pipeline of high-profile films like 'The Mandalorian and Grogu' and 'The Odyssey.' Project Hail Mary has demonstrated strong global appeal, particularly in China.
Insiders have significantly increased their selling activity by 486.11% over the last month. Hedge funds remain neutral, and technical indicators do not suggest a strong buying opportunity. Analyst ratings are mixed, with some maintaining neutral positions despite raising price targets.
In Q4 2025, IMAX achieved a 35.11% YoY revenue increase to $125.2M and a gross margin improvement to 55.96%. However, net income dropped significantly by 87.99% YoY to $637K, and EPS fell by 90.00% YoY to $0.01, indicating profitability challenges.
Analysts have raised price targets, with the highest being $48, but opinions are mixed. Goldman Sachs maintains a Neutral rating, while Benchmark, B. Riley, and JPMorgan have Buy or Overweight ratings, citing strong revenue and margin performance.